Search the Newsreel

Angi (ANGI) Q2 Earnings and Revenues Lag Estimates

AngioDynamics (NASDAQ: ANGO) insider plans $344K sale of equity awards

An insider at AngioDynamics (NASDAQ: ANGO) plans to sell 23,370 shares of common stock, valued at approximately $344,004.06. This proposed sale involves equity awards, specifically restricted stock from 2020 and performance share units from 2021, and will be conducted through Morgan Stanley Smith Barney …

Sanginita Chemicals Ltd. Revenue Breakdown – NSE:SANGINITA

AngioDynamics (ANGO) SVP Warren Nighan Sells 23,370 Shares

Warren Nighan, SVP of Quality and Regulatory at AngioDynamics (ANGO), sold 23,370 shares for approximately $344,006. This transaction occurred on July 30, 2026, and leaves him with 64,745 shares. While the stock is deemed "Significantly Overvalued" by GuruFocus's GF Value model, institutional investors (gurus) …

Form 4 AngioDynamics Inc For: 31 July By Investing.com

This article reports on a Form 4 filing for AngioDynamics Inc. for July 31st. It provides various financial market data, including indices, commodities, bonds, and shares, along with trending stocks and investment strategy suggestions. The core content is the announcement of the Form 4 …

Angiodynamics SVP Warren Nighan Jr sells $344,006 in stock

Warren Nighan Jr., Senior Vice President at AngioDynamics Inc., sold 23,370 shares of company stock for a total of $344,006. This transaction occurred as the stock trades near its 52-week high after a 67% gain, with InvestingPro analysis suggesting it is overvalued. Despite the …

AngioDynamics Inc (ANGO) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for AngioDynamics Inc (ANGO), highlighting its current risk score, industry ranking, and beta value. It details the stock's volatility, maximum drawdown, and return metrics over various periods, emphasizing its tendency to underperform in up-trending markets and experience smaller …

AngioDynamics Inc (ANGO) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of AngioDynamics Inc (ANGO), stating its current valuation score is 7.33, ranking 152 out of 199 in the Healthcare Equipment & Supplies industry. The company's P/E ratio is -19.48, which is significantly below its recent high. It also …

ANGO|AngioDynamics Inc|Price:14.630|Chg%:+0.290

This article provides a comprehensive stock analysis of AngioDynamics Inc (ANGO), highlighting its relatively healthy fundamentals, high growth potential, and fair valuation within the Healthcare Equipment & Supplies industry. It notes high institutional ownership and a recent "Buy" rating from analysts with an expected …

AngioDynamics Number of Employees 2026 | Employee Count & Headcount Data

AngioDynamics, Inc. (ANGO) has 627 employees worldwide as of March 2026, marking a 2.8% decline since 2023 but a 0.1% increase year-over-year. The company is actively hiring, with 58 job postings in 2026, a 39.2% increase from 2025. Its workforce is concentrated in North …

Angi Inc. Revenue Breakdown – NASDAQ:ANGI

AngioDynamics Inc (ANGO) Institutional Confidence

AngioDynamics Inc (ANGO) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 93.94%, a decrease of 11.97% quarter-over-quarter. Steven Cohen is the largest institutional shareholder, holding 3.06 million shares, despite a …

Live webcast set for AngioDynamics' Aug. 11 presentation

AngioDynamics, Inc. announced its management team will participate in upcoming investor conferences, including the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 10, 2026, and Canaccord Genuity's 46th Annual Growth Conference on August 11, 2026. A live webcast of the Canaccord …

Angi (ANGI) to Release Earnings on Tuesday

AngioDynamics Inc (ANGO) Balance Sheet

This article provides key balance sheet information for AngioDynamics Inc (ANGO), including quarterly and annual data for various assets, liabilities, and shareholders' equity components. It allows users to evaluate the company's financial health, analyze fundamentals, and calculate key financial ratios. The data highlights recent …

Q1 Earnings Highs And Lows: Angi (NASDAQ:ANGI) Vs The Rest Of The Gig Economy Stocks

AngioDynamics Inc (ANGO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for AngioDynamics Inc (ANGO) as of April 6. It shows that the majority of its revenue (85.79%, or $67.28M) comes from the United States, with 14.21% ($11.14M) from international regions. The article notes that relevant data for business …

AngioDynamics Inc

AngioDynamics Inc (ANGO) is a medical technology company focused on vascular health and cancer treatment. The company designs, manufactures, and sells devices for vascular access, peripheral vascular disease, oncology, and surgical settings. Its product categories include oncology, venous therapies, vascular interventions, and ports, utilized …

ANGI|Angi Inc|Price:5.530|Chg%:+0.110

Angi Inc. (ANGI) was trading at $5.530, up 2.03% as of July 24, 2026. The company has healthy fundamentals and high growth potential, though its stock price is expected to trend down in the medium term. Analysts currently rate ANGI as "Hold" with a …

AngioDynamics (NASDAQ: ANGO) CEO settles performance share grant

AngioDynamics (NASDAQ: ANGO) CEO James C. Clemmer settled a performance share grant from 2023, receiving 52,358 shares of Common Stock. The original grant of 184,361 units was based on multi-year performance metrics, with the remaining units forfeited. To cover tax withholding obligations, 26,728 shares …

AngioDynamics Inc (ANGO) CFO performance shares vest, tax withheld

AngioDynamics Inc. CFO Stephen A. Trowbridge received 16,296 shares of common stock from the vesting of performance share units, which were part of a target grant of 57,381 units on July 19, 2023. The shares vested based on performance metrics and relative total shareholder …

AngioDynamics (ANGO) SVP receives shares from PSU vesting, with tax withholding

Chad Thomas Campbell, SVP/GM Vascular Access at AngioDynamics (ANGO), received 6,466 shares of common stock from the vesting of performance share units, which were originally granted on July 19, 2023. To cover tax withholding obligations, 2,330 shares were disposed of at $13.82 per share. …

AngioDynamics (NASDAQ: ANGO) executive settles 20,052 performance units

Warren Nighan Jr., SVP Quality and Regulatory at AngioDynamics (NASDAQ: ANGO), had a 2023 performance share unit grant settle, resulting in 5,694 shares of common stock being issued from a target of 20,052 units. The remaining units were forfeited, and 1,671 shares were withheld …

AngioDynamics Inc. (ANGO) SVP receives 8,047 shares, 4,506 withheld for tax

AngioDynamics Inc.'s SVP International, Laura Piccinini, received 8,047 common shares from the vesting of performance share units granted in July 2023. Of these, 4,506 shares were withheld for tax obligations at $13.82 per share, and the remaining 20,289 units from the original grant were …

AngioDynamics Inc. (ANGO) awards 17,966 RSUs and performance rights

AngioDynamics Inc. (ANGO) has granted its SVP of Quality and Regulatory, Warren Nighan Jr., 17,966 restricted stock units (RSUs) and 17,966 performance rights. The RSUs will vest in four equal annual installments from July 2027 to 2030, while the performance rights are tied to …

AngioDynamics (ANGO) awards director Michael Tarnoff 11,887 shares

AngioDynamics director Michael E. Tarnoff received a grant of 11,887 shares of common stock on July 15, 2026. These shares were awarded as restricted stock units for regular annual director compensation and vested immediately upon grant. Following this transaction, Tarnoff directly holds 95,265 common …

AngioDynamics Inc. (ANGO) awards 11,887 RSUs to board director

AngioDynamics Inc. (ANGO) director Wesley Johnson was granted 11,887 restricted stock units (RSUs) on July 15, 2026, as part of his regular annual compensation for board service. These RSUs vested immediately, increasing his direct holdings to 155,425 common shares. The award was processed at …

AngioDynamics (NASDAQ: ANGO) grants RSUs and performance rights to legal chief

AngioDynamics (NASDAQ: ANGO) has granted 21,288 restricted stock units (RSUs) and 21,288 performance rights to its SVP and Chief Legal Officer, Lawrence T. Weiss. The RSUs will vest in four equal annual installments from 2027 to 2030, while the performance rights are tied to …

AngioDynamics Inc (ANGO) director awarded 11,887 shares in annual grant

AngioDynamics Inc. director Howard W. Donnelly was granted 11,887 shares of common stock on July 15, 2026, as part of his regular annual compensation for board service. These shares, representing restricted stock units, vested immediately, increasing his direct holdings to 178,938 shares. This transaction …

RSU grant lifts AngioDynamics Inc. (ANGO) director to 116,921 shares

AngioDynamics Inc. director Jan Stern Reed was granted 11,887 restricted stock units (RSUs) on July 15, 2026, as regular annual compensation for board service. These RSUs immediately vested, increasing Reed's direct holdings to 116,921 common shares. The transaction, reported at $0.00 per share, was …

AngioDynamics (ANGO) director receives 11,887-share stock award

AngioDynamics Inc. (ANGO) director Karen A. Licitra was granted 11,887 shares of common stock on July 15, 2026, as regular annual compensation for her board service. These restricted stock units immediately vested upon grant, increasing her direct holdings to 102,322 shares. The transaction, reported …

AngioDynamics (ANGO) director granted 11,887 immediately vested RSUs

AngioDynamics Inc. director Auen Eileen O'Shea was granted 11,887 restricted stock units (RSUs) as part of her regular annual compensation. These RSUs, which represent 11,887 shares of common stock, vested immediately, increasing her direct holdings to 116,605 shares. The transaction, filed as a Form …

ETFs Investing in AngioDynamics, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold AngioDynamics, Inc. (A0B9A5) stocks, providing investors with diversification opportunities. The ETFs include a range of styles such as passive and active, and focus on small-cap, micro-cap, health care, and total market segments. Key financial …

Form 4 AngioDynamics Inc For: 21 July By Investing.com

This article reports on a Form 4 filing for AngioDynamics Inc (ANGO) on July 21st, published on July 22, 2026. The article itself is very brief, mainly serving as a notification of the filing and providing a current stock performance for ANGO. It appears …

AngioDynamics (ANGO) SVP uses 8,228 shares to cover RSU tax obligations

Laura Piccinini, SVP International at AngioDynamics (ANGO), disposed of a total of 8,228 shares of common stock across three transactions on July 16, 17, and 20, 2026. These dispositions were exempt and made to satisfy tax withholding obligations related to the vesting of restricted …

Tax-withholding of 45,711 shares by AngioDynamics (ANGO) CEO disclosed

AngioDynamics (ANGO) CEO James C. Clemmer reported five exempt dispositions of common stock totaling 45,711 shares between July 16-20, 2026. These transactions were for tax withholding obligations related to the vesting of previously granted Restricted Stock Units (RSUs), with per-share prices ranging from $13.51 …